Hugues De The,Ali Bazarbachi,Hiba El Hajj,Maria Paula Martelli,Brunangelo Falini
申请号：
US15107749
公开号：
US20160317579A1
申请日:
2014.12.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to methods and pharmaceutical compositions for the treatment of acute myeloid leukemia. In particular, the present invention relates to a method for treating NPM-1-driven acute myeloid leukemia (AML) in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one arsenic compound and with a therapeutically effective amount of at least one retinoid.
